Skip to main content
Market intelligence
INMHealthcare

InMed Pharmaceuticals Inc insider activity

In the last 90 days, 6 corporate insiders purchased $3,009,379 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$3,009,379
Corporate buyers
6
Latest transaction
Jun 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 8, 2026Vivo Opportunity LlcCorporate insiderOpen Market Purchase249,227$1.57$391,561
Jun 8, 2026Vivo Opportunity Cayman Fund L.p.Corporate insiderOpen Market Purchase249,227$1.57$391,561
Jun 8, 2026Vivo Opportunity Cayman LlcCorporate insiderOpen Market Purchase249,227$1.57$391,561